Insulin Glargine U300 (Toujeo®)

Assessment Status Rapid Review Complete
Drug Insulin Glargine U300
Brand Toujeo®
Indication for the treatment of diabetes mellitus in adults.
Assessment Process
Rapid review commissioned 14/05/2015
Rapid review completed 02/07/2015
Rapid review outcome Full Pharmacoeconomic Assessment Recommended at the Submitted Price

The HSE has approved reimbursement following confidential price negotiations.